Tarsus Pharmaceuticals Inc Cash Flow Reinvestment Rate
Tarsus Pharmaceuticals Inc cash flow reinvestment rate. Tarsus Pharmaceuticals Inc (TARS) has a Cash Flow Reinvestment Rate of 0.69x as of June 2026, reinvesting $46.02 Million (capex $4.07 Million plus investments $41.95 Million) from operating cash flow of $66.77 Million. Explore cash flow to debt ratio of Tarsus Pharmaceuticals Inc to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Tarsus Pharmaceuticals Inc (2021–2021)
Cash flow reinvestment rate of Tarsus Pharmaceuticals Inc from 2021 to 2021. Historical reinvestment intensity for Tarsus Pharmaceuticals Inc across 1 annual periods. Explore TARS capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.
Tarsus Pharmaceuticals Inc Cash Flow Reinvestment Rate by Year (2021–2021)
Tarsus Pharmaceuticals Inc cash flow reinvestment rate by year from 2021 to 2021. Year-by-year capital reinvestment analysis for Tarsus Pharmaceuticals Inc. For the full cash flow conversion analysis, see Tarsus Pharmaceuticals Inc (TARS) cash conversion ratio.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2021 | 0.31x | $1.17 Million | $3.75 Million | $586.00K | — |